Small cell carcinomas of the prostate are rare. These tumors exhibit m
orphologic and functional neuro-endocrine characteristics. They are a
highly agressive. New therapeutic protocols are being developed in ord
er to be effective against these tumors, particularly those unresponsi
ve to hormonotherapy.